Inhibitory ACE (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibitory ACE" in Czech language version.

refsWebsite
Global rank Czech rank
4th place
8th place
2nd place
4th place
1st place
1st place
3,840th place
1,363rd place
1,903rd place
5,340th place
719th place
451st place
2,374th place
1,252nd place

doi.org

dx.doi.org

  • AJAYI, Adesuyi A.; CAMPBELL, Brian C.; HOWIE, Catherine A.; REID, John L. Acute and chronic effects of the Converting Enzyme Inhibitors Enalapril and Lisinopril on Reflex Control of Heart Rate in Normotensive Man. Journal of Hypertension. 1985, s. 47–53. DOI 10.1097/00004872-198502000-00008. PMID 2987341. 
  • BINKLEY, PF; HAAS, GJ; STARLING, RC; NUNZIATA, E; HATTON, PA; LEIER, CV; CODY, RJ. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol. 1 Mar 1993, s. 655–61. DOI 10.1016/0735-1097(93)90098-L. PMID 8436747. 
  • ADIGUN, A; AJAYI, AA. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. European Journal of Heart Failure. 2001, s. 359–63. DOI 10.1016/S1388-9842(00)00146-X. PMID 11378008. 
  • ANKER, S; PONIKOWSKI, P; VARNEY, S; CHUA, T; CLARK, A; WEBBPEPLOE, K; HARRINGTON, D. Wasting as independent risk factor for mortality in chronic heart failure. The Lancet. 1997, s. 1050–3. DOI 10.1016/S0140-6736(96)07015-8. PMID 9107242. 
  • Fein A. ACE inhibitors worsen inflammatory pain. Medical Hypotheses. 2009, s. 757. DOI 10.1016/j.mehy.2009.01.012. 
  • OKUMURA, Hiromi; NISHIMURA, Eriko; KARIYA, Satoru; OHTANI, Michiteru; UCHINO, Katsuyoshi; FUKATSU, Tohru; ODANAKA, Jun. Angiotensin-converting enzyme (ACE)阻害薬誘発性の咳嗽発現とACE 遺伝子型,血漿中ブラジキニン,サブスタンスP 及びACE 阻害薬濃度との関連性. Yakugaku Zasshi. 2001, s. 253–7. Dostupné v archivu pořízeném dne 2017-12-29. DOI 10.1248/yakushi.121.253. PMID 11265121. (Japanese)  Archivovaná kopie. www.jstage.jst.go.jp [online]. [cit. 2013-04-20]. Dostupné v archivu pořízeném z originálu dne 2017-12-29. 
  • Molinaro; CUGNO, M; PEREZ, M; LEPAGE, Y; GERVAIS, N; AGOSTONI, A; ADAM, A. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin. The Journal of Pharmacology and Experimental Therapeutics. 2002, s. 232–7. DOI 10.1124/jpet.102.038067. PMID 12235256. 
  • THEACUTEINFARCTIONRAMIPRILEFFI. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet. 1993, s. 821–8. DOI 10.1016/0140-6736(93)92693-N. PMID 8104270. 
  • DIMOPOULOS, K, Salukhe, Coats, Mayet, Piepoli, Francis. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int J Cardiol. 2004, s. 105–111. DOI 10.1016/j.ijcard.2003.10.001. PMID 14975535. 
  • Luno; PRAGA, M; DE VINUESA, SG. The reno-protective effect of the dual blockade of the renin angiotensin system (RAS). Current pharmaceutical design. 2005, s. 1291–300. DOI 10.2174/1381612053507413. PMID 15853685. 
  • Van De Wal; VAN VELDHUISEN, DJ; VAN GILST, WH; VOORS, AA. Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?. European Heart Journal. 2005, s. 2361–7. DOI 10.1093/eurheartj/ehi454. PMID 16105846. 
  • Finnegan; GLEASON, BL. Combination ACE inhibitors and angiotensin II receptor blockers for hypertension. The Annals of pharmacotherapy. 2003, s. 886–9. DOI 10.1345/aph.1C393. PMID 12773079. 
  • Krum; CARSON, P; FARSANG, C; MAGGIONI, AP; GLAZER, RD; AKNAY, N; CHIANG, YT. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT. European Journal of Heart Failure. 2004, s. 937–45. DOI 10.1016/j.ejheart.2004.09.005. PMID 15556056. 
  • Solomon; SKALI, H; ANAVEKAR, NS; BOURGOUN, M; BARVIK, S; GHALI, JK; WARNICA, JW. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation. 2005, s. 3411–9. DOI 10.1161/CIRCULATIONAHA.104.508093. PMID 15967846. 

jst.go.jp

jstage.jst.go.jp

  • OKUMURA, Hiromi; NISHIMURA, Eriko; KARIYA, Satoru; OHTANI, Michiteru; UCHINO, Katsuyoshi; FUKATSU, Tohru; ODANAKA, Jun. Angiotensin-converting enzyme (ACE)阻害薬誘発性の咳嗽発現とACE 遺伝子型,血漿中ブラジキニン,サブスタンスP 及びACE 阻害薬濃度との関連性. Yakugaku Zasshi. 2001, s. 253–7. Dostupné v archivu pořízeném dne 2017-12-29. DOI 10.1248/yakushi.121.253. PMID 11265121. (Japanese)  Archivovaná kopie. www.jstage.jst.go.jp [online]. [cit. 2013-04-20]. Dostupné v archivu pořízeném z originálu dne 2017-12-29. 

medicinenet.com

  • Ogbru O. ACE Inhibitors (Angiotensin Converting Enzyme Inhibitors) [online]. MedicineNet, Inc [cit. 2010-03-20]. Dostupné v archivu pořízeném z originálu dne 2010-03-26. 

medscape.com

nejm.org

nih.gov

ncbi.nlm.nih.gov

  • ROCHA E SILVA M., BERALDO WT., ROSENFELD G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. „Am J Physiol”. Feb;156. 2, s. 261–73, 1949. PMID 18127230.
  • Bakhle YS. Inhibition of angiotensin I converting enzyme by venom peptides. „Br J Pharmacol”. Sep;43. 1, s. 252–4, 1972. PMID 4332776
  • Ondetti MA., Williams NJ., Sabo EF., Pluscec J., Weaver ER., Kocy O. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. „Biochemistry”. Oct 26;10. 22, s. 4033–9, 1972. PMID 4334402.
  • Gavras H., Brunner HR., Laragh JH., Sealey JE., Gavras I., Vukovich RA. An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. „N Engl J Med”. Oct 17;291. 16, s. 817–21, 1974. PMID 4371298.
  • Hoogwerf; YOUNG, JB. The HOPE study. Lowered cardiovascular risk, but vitamin E did not. Cleveland Clinic journal of medicine. 2000, s. 287–93. PMID 10780101. 
  • AJAYI, Adesuyi A.; CAMPBELL, Brian C.; HOWIE, Catherine A.; REID, John L. Acute and chronic effects of the Converting Enzyme Inhibitors Enalapril and Lisinopril on Reflex Control of Heart Rate in Normotensive Man. Journal of Hypertension. 1985, s. 47–53. DOI 10.1097/00004872-198502000-00008. PMID 2987341. 
  • ADIGUN, AQ, Asiyanbola B, Ajayi AA. Cardiac autonomic function in Blacks with congestive heart failure: vagomimetic action, alteration in sympathovagal balance, and the effect of ACE inhibition on central and peripheral vagal tone. Cell Mol Biol (Noisy le grande). 2001, s. 1063–7. PMID 11785658. 
  • BINKLEY, PF; HAAS, GJ; STARLING, RC; NUNZIATA, E; HATTON, PA; LEIER, CV; CODY, RJ. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol. 1 Mar 1993, s. 655–61. DOI 10.1016/0735-1097(93)90098-L. PMID 8436747. 
  • ADIGUN, A; AJAYI, AA. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. European Journal of Heart Failure. 2001, s. 359–63. DOI 10.1016/S1388-9842(00)00146-X. PMID 11378008. 
  • ANKER, S; PONIKOWSKI, P; VARNEY, S; CHUA, T; CLARK, A; WEBBPEPLOE, K; HARRINGTON, D. Wasting as independent risk factor for mortality in chronic heart failure. The Lancet. 1997, s. 1050–3. DOI 10.1016/S0140-6736(96)07015-8. PMID 9107242. 
  • OKUMURA, Hiromi; NISHIMURA, Eriko; KARIYA, Satoru; OHTANI, Michiteru; UCHINO, Katsuyoshi; FUKATSU, Tohru; ODANAKA, Jun. Angiotensin-converting enzyme (ACE)阻害薬誘発性の咳嗽発現とACE 遺伝子型,血漿中ブラジキニン,サブスタンスP 及びACE 阻害薬濃度との関連性. Yakugaku Zasshi. 2001, s. 253–7. Dostupné v archivu pořízeném dne 2017-12-29. DOI 10.1248/yakushi.121.253. PMID 11265121. (Japanese)  Archivovaná kopie. www.jstage.jst.go.jp [online]. [cit. 2013-04-20]. Dostupné v archivu pořízeném z originálu dne 2017-12-29. 
  • Thomas. Diuretics, ACE inhibitors and NSAIDs--the triple whammy. The Medical journal of Australia. 2000, s. 184–5. PMID 10772593. 
  • Cohn; KOWEY, PR; WHELTON, PK; PRISANT, LM. New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. The Archives of Internal Medicine. 2000, s. 2429–36. PMID 10979053. 
  • Molinaro; CUGNO, M; PEREZ, M; LEPAGE, Y; GERVAIS, N; AGOSTONI, A; ADAM, A. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin. The Journal of Pharmacology and Experimental Therapeutics. 2002, s. 232–7. DOI 10.1124/jpet.102.038067. PMID 12235256. 
  • Sørensen AM, Christensen S, Jonassen TE, Andersen D, Petersen JS. [Teratogenic effects of ACE-inhibitors and angiotensin II receptor antagonists]. Ugeskrift for Laeger. 1998, s. 1460–4. PMID 9520613. (Danish) 
  • Aihara; KAJIMOTO, O; HIRATA, H; TAKAHASHI, R; NAKAMURA, Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. Journal of the American College of Nutrition. 2005, s. 257–65. PMID 16093403. 
  • THEACUTEINFARCTIONRAMIPRILEFFI. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet. 1993, s. 821–8. DOI 10.1016/0140-6736(93)92693-N. PMID 8104270. 
  • DIMOPOULOS, K, Salukhe, Coats, Mayet, Piepoli, Francis. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int J Cardiol. 2004, s. 105–111. DOI 10.1016/j.ijcard.2003.10.001. PMID 14975535. 
  • Luno; PRAGA, M; DE VINUESA, SG. The reno-protective effect of the dual blockade of the renin angiotensin system (RAS). Current pharmaceutical design. 2005, s. 1291–300. DOI 10.2174/1381612053507413. PMID 15853685. 
  • Van De Wal; VAN VELDHUISEN, DJ; VAN GILST, WH; VOORS, AA. Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?. European Heart Journal. 2005, s. 2361–7. DOI 10.1093/eurheartj/ehi454. PMID 16105846. 
  • Finnegan; GLEASON, BL. Combination ACE inhibitors and angiotensin II receptor blockers for hypertension. The Annals of pharmacotherapy. 2003, s. 886–9. DOI 10.1345/aph.1C393. PMID 12773079. 
  • Krum; CARSON, P; FARSANG, C; MAGGIONI, AP; GLAZER, RD; AKNAY, N; CHIANG, YT. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT. European Journal of Heart Failure. 2004, s. 937–45. DOI 10.1016/j.ejheart.2004.09.005. PMID 15556056. 
  • Solomon; SKALI, H; ANAVEKAR, NS; BOURGOUN, M; BARVIK, S; GHALI, JK; WARNICA, JW. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation. 2005, s. 3411–9. DOI 10.1161/CIRCULATIONAHA.104.508093. PMID 15967846. 
  • Yang; OHTA, K; SHIMIZU, M; NAKAI, A; KASAHARA, Y; YACHIE, A; KOIZUMI, S. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy. Clinical nephrology. 2005, s. 35–40. PMID 16047643. 

web.archive.org

  • Ogbru O. ACE Inhibitors (Angiotensin Converting Enzyme Inhibitors) [online]. MedicineNet, Inc [cit. 2010-03-20]. Dostupné v archivu pořízeném z originálu dne 2010-03-26. 
  • OKUMURA, Hiromi; NISHIMURA, Eriko; KARIYA, Satoru; OHTANI, Michiteru; UCHINO, Katsuyoshi; FUKATSU, Tohru; ODANAKA, Jun. Angiotensin-converting enzyme (ACE)阻害薬誘発性の咳嗽発現とACE 遺伝子型,血漿中ブラジキニン,サブスタンスP 及びACE 阻害薬濃度との関連性. Yakugaku Zasshi. 2001, s. 253–7. Dostupné v archivu pořízeném dne 2017-12-29. DOI 10.1248/yakushi.121.253. PMID 11265121. (Japanese)  Archivovaná kopie. www.jstage.jst.go.jp [online]. [cit. 2013-04-20]. Dostupné v archivu pořízeném z originálu dne 2017-12-29.